U.S. market Closed. Opens in 3 hours 1 minute

THW | Tekla World Healthcare Fund Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for THW we got that it has weak fundamentals where Valuation is considered to be slightly undervalued, Profitability is moderate, Growth is very bad and Health is frighteningly weak.

Valuation (64%)

Company Industry
P/E Ratio (TTM) 9.85 38.04
PEG Ratio (TTM) 0.03 5.34
P/S Ratio (TTM) 11.46 68.89
P/B Ratio (TTM) 1.01 71.89
P/FCF Ratio (TTM) -64.16 84.53
Price to 5YR AVG Earnings Ratio 19.33 12.87
Price to 5YR AVG FCF Ratio 77.07 47.37

Profitability (55%)

Company Industry
ROA (TTM) 8.14% 643.78%
ROE (TTM) 10.57% 9.93%
Net Profit Margin (TTM) 117.15% -12.87%
ROIC 5YR AVG 2.80% 15.66%

Growth (35%)

4QTR AVG 3YR AVG 5YR AVG
EPS 13.31% -49.70% -5.37%
Revenue 580.33% -43.85% 6.43%
Net Income 15.65% -44.67% 5.17%
Cash Flow -641.95% -19.12% -12.96%

Health (30%)

Company Industry
Current Ratio (TTM) N/A 4.98
Quick Ratio (TTM) N/A 4.39
D/E Ratio (TTM) 0.25 0.82
Interest Coverage (TTM) 7.22 8.69
Piotroski F-Score 5 6
Altman Z-Score 2.35 6.34
LTL to 5YR AVG FCF 19.30 7.49
Shares Outstanding Growth 5YR AVG 6.47% 3.59%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙